If you observe any of these symptoms of a heart problem, take your child to your primary care physician. They will refer you to a pediatric cardiologist – children’s heart specialist for further tests”

— Dr. Kamal Pourmoghadam, Orlando, Florida

ORLANDO, FLORIDA, UNITED STATES, May 31, 2019 /EINPresswire.com/ — Did you know that one in every 100 children suffer from a heart problem? This includes heart defects that may be present from birth, or developed at birth, or turned into a defect as the child grew up. These defects are usually treated with the help of medicine, surgery, or several medical procedures combined.

At times, it is difficult to identify a heart defect, and many children continue to live a normal life with little to no problems. However, in some cases, children may find difficulty in performing normal tasks such as running or walking due to a heart problem. This happens when the heart problem goes undetected at an earlier stage and becomes a huge health concern later on in life.

Hence, heart defects must be treated as soon as possible and to detect them in the first place, the following are some symptoms that you must watch out for.

Common Signs and Symptoms of Heart Problems in Children

Heart problems can occur in infants, toddlers, and older children, and these children may exhibit the following symptoms concerning heart defects:
1. Infants
* Feeling out of breath when feeding milk
* Becoming sweaty during feeds
* Gums or tongue turning blue
* Passing out

2. Toddlers
* Failing to stay as active as other children
* Feeling fatigued and getting out of breath during simple activities as compared to other kids of that age
* Getting sweaty quicker than other kids. Sometimes after even less activity than other children.
* Blue skin color (gums/tongue)
* Frequent fainting
3. Teens
* Chest pain while performing exercises
* Fatigue and dizziness
* Passing out
* Swelling in the legs, abdomen, and skin around the eyes
* Shortness of breath during exercise or while playing sports
* Getting tired easily

When to See a Doctor

If you observe any of these symptoms of a heart problem, take your child to your primary care physician. They will refer you to a pediatric cardiologist – children’s heart specialist. The children’s heart specialist will perform the necessary tests to diagnose the type of heart defect your child is suffering from.

Some of the tests that a pediatric cardiologist will conduct are:

* Chest X-ray which is a simple X-ray to identify any hole or lump in the chest.
* An ECG is another test in which wires are attached using sticky dots on the chest, arms, and legs. These wires diagnose the electrical activity of the heart. This test takes only a few minutes and doesn’t cause any sort of pain. However, your child will be required to stay composed during the test.
* An ultrasound scan, known as an echocardiogram, will also be conducted. In this type of test, a handheld scanner scans the chest and stomach and presents your child’s heart’s image on a TV monitor. In this test, your child may feel pressure as the scanner is pressed firmly against the skin. So, it can be uncomfortable. However, it is not painful.
Some common treatments for heart defects are medicines, surgery, and procedures like using a catheter to stop blood from flowing in between the chambers, etc.

Dr. Kamal Pourmoghadam is a pediatric cardiac surgeon at The Heart Center at Arnold Palmer Hospital for Children. He is board certified in general surgery, cardiothoracic surgery and congenital cardiac surgery.

Dr. Pourmoghadam earned his bachelor’s degree from University of California, Berkeley, and his medical degree from Albany Medical College in New York. He trained for adult cardiac surgery at the University of Miami, Jackson Memorial Hospital in Miami, and for congenital cardiac surgery at the University of Washington, Seattle Children’s Hospital in Seattle.

Dr. Pourmoghadam is a professor of surgery at the University of Central Florida College of Medicine, practicing congenital cardiac surgery for over twenty years and has been active in clinical research. He has extensive experience in neonatal and infant cardiac surgery and has special interest in the repair of single ventricle physiology patients and research in univentricular hearts.

The Business Research Company adds "Nursing Care Market By Service Type, By End-User, By Type Of Expenditure, Key Company Profiles and Global 2022 Forecasts

The Top Opportunities In The Global Nursing Care Market Will Arise In The Nursing Care Facilities Segment Which Will Gain $126.1 Billion Of Global Annual Sales By 2022.”

— Abdul Wasay

LONDON, GREATER LONDON, UK, May 31, 2019 /EINPresswire.com/ — The global market for nursing care is expected to reach a value of nearly above $1 trillion by 2022, having grown at an annual rate of above 8% since 2018.

Growth in the nursing care market in the historic period resulted from the rapid growth in the size of the elderly population, strong economic growth in emerging markets, changes in social patterns, and health insurance reforms. Factors that negatively affected growth in the historic period were low healthcare access in some countries, shortages of skilled human resources, lack of insurance coverage and weak wage growth in developed economies. Going forward, faster economic growth, technological developments and increasingly busy and sedentary lifestyles will drive growth. Factors that could hinder the growth of this market in the future include shortages of skilled human resources, insufficient public health insurance coverage, and a rising number of home health entities falling into insolvency.

The top opportunities in the global nursing care market will arise in the nursing care facilities segment, which will gain more than $126 billion of global annual sales by 2022. The nursing care market size will gain the most in the USA at $55.23 billion. Nursing care market-trend-based strategies include the launch of integrated care services, implementation of remote patient monitoring and health management programs, and the launch of custom-care packages. Player-adopted strategies in the nursing care industry include expansion through mergers and acquisitions and construction of new medical centers.

To take advantage of the opportunities, The Business Research Company recommends the nursing care companies to consider increasing remote controlled self-diagnosis services, expanding in emerging markets, focusing on expanding through collaborations, implementing competitive pricing, leveraging social media to maximize reach, increasing visibility through a high-performance website, and offering services for aged women.

The global nursing care market is highly fragmented. The top ten competitors in the global nursing care market made up 3.1% of the total market in 2018. Players in the market include Genesis Healthcare, Kaiser Permanente, Brookdale Senior Living, Kindred Healthcare, LLC and The Ensign Group, Inc.

Where To Learn More Read Nursing Care Market By Service Type (Nursing Care Facilities, Home Health Care Providers, Retirement Communities, Group Care Homes); By End-User Gender (Female, Male); By Type Of Expenditure (Public, Private) – Global Forecast To 2022 from The Business Research Company for information on the following:

Strategies For Participants In The Nursing Care Industry: The report explains a number of strategies for companies in the nursing care market, based on industry trends and company analysis.

Opportunities For Companies In The Nursing Care Sector: The report reveals where the global nursing care industry will put on most $ sales up to 2022.

Interested to know more about The Business Research Company? The Business Research Company has published over 300 industry reports, covering over 2400 market segments and 56 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. Here is a list of reports from The Business Research Company similar to Nursing Care Market By Service Type (Nursing Care Facilities, Home Health Care Providers, Retirement Communities, Group Care Homes); By End-User Gender (Female, Male); By Type Of Expenditure (Public, Private) – Global Forecast To 2022:

Hospitals And Clinics Market By Service Type (Hospitals, Clinics); By End User-Gender (Female, Male); By Expenditure (Public, Private) – Global Forecast To 2022

Dental Services Market By Type (General Dentistry, Orthodontics And Prosthodontics And Oral Surgery), By End Use Industry, By Country, By Competitor And Regional Analysis – Global Forecast To 2022

ROSEVILLE, CALIFORNIA, USA, May 31, 2019 /EINPresswire.com/ — Healthcare professional Himachal Mukhopadhyay has studied developing trends of biosimilars for decades. He helps shed light on FDA-approved biosimilar medications and their implications for patients now and in the future.

Himachal Mukhopadhyay has over 20 years in the healthcare industry, where he’s taken on roles in Operations, Delivery, Engineering, and Sales/Business Development. As a leader and strategic advisor, he studies ongoing healthcare trends to provide in-depth research and creative solutions to his clients. Below, he remarks on the recent advancements in biological medicine and the increase of FDA-approved biosimilars, which have major implications for healthcare patients around the world.

“Last year, the number of FDA-approved biosimilars nearly doubled thanks to advancements in technology and research,” says Himachal Mukhopadhyay. “Because of these approvals, patients everywhere can have access to specialized biological treatments at a much lower cost.”

Biological Medicine vs. Conventional Medication

Biological products are advanced scientific discoveries that encompass products like vaccines, gene therapy, blood components, and recombinant therapeutic proteins. Biologics are composed of a range of substances and often include living entities like tissues and cells to deliver effective treatment results where no other treatments may be available.

Conventional medication is largely made up of chemically-synthesized ingredients whose structures are well known after years of study and development. Biological medicine, on the other hand, is made up of complex biological mixtures that implement cutting-edge biomedical research to treat illnesses and conditions. In addition, these medications are more susceptible to damage from heat and microbial contamination. This tends to drive up the cost for healthcare patients as do the patented ingredients, processes, and price of past research.

Biosimilars Offer Nearly-Identical Alternatives

Himachal Mukhopadhyay notes that because biologics are so complex and specialized, they tend to be highly expensive and not a valid option for many patients whose illnesses or conditions could otherwise benefit from them. Biosimilars are copycat formulas of approved biologic medicine. The effectiveness of a biosimilar medication is tested against the effectiveness of the reference product in extensive laboratory and clinical research to determine if it’s a viable option for healthcare patients.

Before a biosimilar can be released for public use, it first must prove that it produces no meaningful differences from the product it imitates in terms of effectiveness and safety. Recently, the FDA has approved more biosimilars than ever, creating generic alternatives for patients around the world.

Biosimilars Mean Cheaper Treatment Options for Many

The biggest benefit of biosimilars for patients is the difference in cost. Patented formulas allow manufacturers to control pricing as they see fit, but biosimilars give competitors and secondary manufacturers the opportunity to provide similar medication at a fraction of the cost (similar to brand name medications and their generic counterparts).

“As the FDA approves more and more biosimilars, healthcare patients can expect to encounter more specialized treatment and care at much more affordable pricing,” says Himachal Mukhopadhyay. “In the future, this will mean greater access to complex medicine for international patients and ultimately a much healthier populace as a result.”

Wiseguyreports.Com adds “Anti-bleeding Drugs Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Anti-bleeding Drugs Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Anti-bleeding Drugs Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global market size of Anti-bleeding Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-bleeding Drugs in these regions. This research report categorizes the global Anti-bleeding Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This reprot mainly studies Anti-bleeding Drugs market, Anti-bleeding Drugs are drugs that prevent or reduce coagulation of blood, prolonging the clotting time. Global Anti-bleeding Drug market is showing a positive trend of growth around the globe. There are many factors which are indicating a positive outlook of this market for medium and long term. The increasing aging population is a key driver for the global Anti-bleeding Drug market. The objectives of this study are to define, segment, and project the size of the Anti-bleeding Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Anti-bleeding Drugs include manufacturers, suppliers, distributors, intermediaries, and customers.

Wiseguyreports.Com adds “Medical Waste Management Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Medical Waste Management Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Medical Waste Management Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

In this report, we analyze the Medical Waste Management industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2013 to 2018. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2013 to 2018. We also make a prediction of its production and consumption in coming 2018–2023.

Wiseguyreports.Com adds “Pharmaceuticals Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Pharmaceuticals Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Pharmaceuticals Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report focuses on the global Pharmaceuticals status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceuticals development in United States, Europe and China.

The pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is inarguable. North America is responsible for the largest portion of these revenues, due to the leading role of the U.S. pharmaceutical industry. However, as in many other industries, the Chinese pharmaceutical sector has shown the highest growth rates over previous years. In 2017, the global Pharmaceuticals market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of 5.2% during 2018–2025.

Wiseguyreports.Com adds “Breast Reconstruction and Augmentation Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Breast Reconstruction and Augmentation Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Breast Reconstruction and Augmentation Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Breast reconstruction can repurpose existing skin and fat. While breast augmentation utilizes a synthetic saline or silicone-filled implant.In 2018, the global Breast Reconstruction and Augmentation market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019–2025.

This report focuses on the global Breast Reconstruction and Augmentation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Reconstruction and Augmentation development in United States, Europe and China.

Wiseguyreports.Com adds “Compounding Pharmacy Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Compounding Pharmacy Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Compounding Pharmacy Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can’t be met by commercially available drugs. For example:A young child may need a small, liquid dose of a drug made only in adult-dosage tablets.A person may be allergic to one of the ingredients in the commercial version of a drug.A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients.Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.The classification of Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2017 is about 34%.Compounding Pharmacy is widely used for consumers aged 18 and younger, consumers aged 19 to 44, consumers aged 45 to 64, consumers aged 65 and older. The most proportion of compounding pharmacy is consumers aged 45 to 64, and the proportion in 2017 is 40.7%.North America is the largest market for compounding pharmacy, with a market share nearly 57% in 2017. Following North America, Europe is the second largest market with the consumption market share of 25%.Market competition is not intense Fagron, Wedgewood Pharma, CAPS, Fresenius Kabi, Advanced Pharma, PharMEDium Services are the leaders of the industry, with high-end customers in the industry.In 2018, the global Compounding Pharmacy market size was 10300 million US$ and it is expected to reach 12800 million US$ by the end of 2025, with a CAGR of 2.8% during 2019–2025.

This report focuses on the global Compounding Pharmacy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Compounding Pharmacy development in United States, Europe and China.

Wiseguyreports.Com adds “Pharmaceutical Drug Delivery Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Pharmaceutical Drug Delivery Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Pharmaceutical Drug Delivery Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effectThe global Pharmaceutical Drug Delivery market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019–2025. The objectives of this study are to define, segment, and project the size of the Pharmaceutical Drug Delivery market based on company, product type, end user and key regions.

Wiseguyreports.Com adds “Radiopharmaceuticals Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Radiopharmaceuticals Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Radiopharmaceuticals Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.The global Radiopharmaceuticals market is valued at 4900 million US$ in 2018 and will reach 8410 million US$ by the end of 2025, growing at a CAGR of 8.0% during 2019–2025. The objectives of this study are to define, segment, and project the size of the Radiopharmaceuticals market based on company, product type, end user and key regions.

This report studies the global market size of Radiopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Radiopharmaceuticals in these regions.This research report categorizes the global Radiopharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Radiopharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.